Author Interviews, Brigham & Women's - Harvard, Cancer Research, JAMA, Radiation Therapy, Technology / 19.04.2019
AI Poised to Revolutionize Radiation Therapy for Cancer
MedicalResearch.com Interview with:
Raymond H Mak, MD
Radiation Oncology
Brigham and Women's Hospital
MedicalResearch.com: What is the background for this study?
- Lung cancer remains the most common cancer, and leading cause of cancer mortality, in the world and ~40-50% of lung cancer patients will need radiation therapy as part of their care
- The accuracy and precision of lung tumor targeting by radiation oncologists can directly impact outcomes, since this key targeting task is critical for successful therapeutic radiation delivery.
- An incorrectly delineated tumor may lead to inadequate dose at tumor margins during radiation therapy, which in turn decreases the likelihood of tumor control.
- Multiple studies have shown significant inter-observer variation in tumor target design, even among expert radiation oncologists
- Expertise in targeting lung tumors for radiation therapy may not be available to under-resourced health care settings
- Some more information on the problem of lung cancer and the radiation therapy targeting task here:https://www.youtube.com/watch?v=An-YDBjFDV8&feature=youtu.be